UA113048C2 - ANTI-VIRUS COMPOUNDS - Google Patents
ANTI-VIRUS COMPOUNDSInfo
- Publication number
- UA113048C2 UA113048C2 UAA201305877A UAU201305877A UA113048C2 UA 113048 C2 UA113048 C2 UA 113048C2 UA A201305877 A UAA201305877 A UA A201305877A UA U201305877 A UAU201305877 A UA U201305877A UA 113048 C2 UA113048 C2 UA 113048C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- virus
- virus compounds
- methods
- hcv
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000002155 anti-virotic effect Effects 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Описано сполуки, ефективні при інгібуванні реплікації вірусу гепатиту С (ВГС). Даний винахід стосується також способів одержання таких сполук, композицій, що містять такі сполуки, способів застосування таких сполук для лікування ВІЛ-інфекції.Compounds that are effective in inhibiting hepatitis C virus (HCV) replication are described. The present invention also relates to methods of producing such compounds, compositions containing such compounds, methods of using such compounds for the treatment of HIV.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/903,822 US20110092415A1 (en) | 2009-06-11 | 2010-10-13 | Anti-Viral Compounds |
US12/964,027 US8921514B2 (en) | 2009-06-11 | 2010-12-09 | Anti-viral compounds |
US201161446800P | 2011-02-25 | 2011-02-25 | |
US13/100,827 US8937150B2 (en) | 2009-06-11 | 2011-05-04 | Anti-viral compounds |
PCT/US2011/056045 WO2012051361A1 (en) | 2010-10-13 | 2011-10-12 | Anti-viral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
UA113048C2 true UA113048C2 (en) | 2016-12-12 |
Family
ID=55069204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201305877A UA113048C2 (en) | 2010-10-13 | 2011-12-10 | ANTI-VIRUS COMPOUNDS |
Country Status (19)
Country | Link |
---|---|
JP (4) | JP2016106075A (en) |
KR (1) | KR101990936B1 (en) |
CA (1) | CA2938547A1 (en) |
CY (1) | CY1117188T1 (en) |
DK (1) | DK2692346T3 (en) |
ES (1) | ES2560842T3 (en) |
GT (1) | GT201300093AA (en) |
HK (1) | HK1188717A1 (en) |
HR (1) | HRP20151389T1 (en) |
HU (1) | HUE026832T2 (en) |
IL (2) | IL225010A (en) |
ME (1) | ME02328B (en) |
MY (1) | MY164064A (en) |
PT (1) | PT2692346E (en) |
RS (1) | RS54619B1 (en) |
SI (1) | SI2692346T1 (en) |
TW (1) | TWI621611B (en) |
UA (1) | UA113048C2 (en) |
ZA (3) | ZA201302269B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201706806D0 (en) | 2017-04-28 | 2017-06-14 | Sentinel Oncology Ltd | Pharmaceutical compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007128A1 (en) * | 1991-10-11 | 1993-04-15 | The Du Pont Merck Pharmaceutical Company | Cyclic ureas and analogues useful as retroviral protease inhibitiors |
US5840721A (en) * | 1997-07-09 | 1998-11-24 | Ontogen Corporation | Imidazole derivatives as MDR modulators |
US8329159B2 (en) * | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7741347B2 (en) * | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
BRPI0922364A2 (en) * | 2008-12-03 | 2017-08-29 | Presidio Pharmaceuticals Inc | COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND |
US9394279B2 (en) * | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
US8937150B2 (en) * | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
CN102333772B (en) * | 2009-06-11 | 2013-12-11 | 雅培制药有限公司 | Anti-viral compounds |
-
2011
- 2011-10-12 PT PT131910416T patent/PT2692346E/en unknown
- 2011-10-12 ES ES13191041.6T patent/ES2560842T3/en active Active
- 2011-10-12 HU HUE13191041A patent/HUE026832T2/en unknown
- 2011-10-12 SI SI201130697T patent/SI2692346T1/en unknown
- 2011-10-12 TW TW102143104A patent/TWI621611B/en active
- 2011-10-12 KR KR1020187004491A patent/KR101990936B1/en active IP Right Grant
- 2011-10-12 DK DK13191041.6T patent/DK2692346T3/en active
- 2011-10-12 ME MEP-2016-14A patent/ME02328B/en unknown
- 2011-10-12 MY MYPI2013700273A patent/MY164064A/en unknown
- 2011-10-12 CA CA2938547A patent/CA2938547A1/en not_active Abandoned
- 2011-10-12 RS RS20160128A patent/RS54619B1/en unknown
- 2011-12-10 UA UAA201305877A patent/UA113048C2/en unknown
-
2013
- 2013-02-28 IL IL225010A patent/IL225010A/en active IP Right Grant
- 2013-03-26 ZA ZA2013/02269A patent/ZA201302269B/en unknown
-
2014
- 2014-01-13 GT GT201300093AK patent/GT201300093AA/en unknown
- 2014-02-25 HK HK14101772.6A patent/HK1188717A1/en unknown
-
2015
- 2015-10-29 JP JP2015212539A patent/JP2016106075A/en active Pending
- 2015-12-17 HR HRP20151389TT patent/HRP20151389T1/en unknown
-
2016
- 2016-02-12 CY CY20161100115T patent/CY1117188T1/en unknown
-
2017
- 2017-08-15 ZA ZA2017/05519A patent/ZA201705519B/en unknown
- 2017-11-22 JP JP2017224527A patent/JP6586147B2/en active Active
-
2018
- 2018-08-16 IL IL261206A patent/IL261206B/en active IP Right Grant
-
2019
- 2019-05-24 ZA ZA2019/03284A patent/ZA201903284B/en unknown
- 2019-09-05 JP JP2019161909A patent/JP6790202B2/en active Active
-
2020
- 2020-11-02 JP JP2020183474A patent/JP2021035964A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021035964A (en) | 2021-03-04 |
MY164064A (en) | 2017-11-15 |
CA2938547A1 (en) | 2012-04-19 |
DK2692346T3 (en) | 2016-02-29 |
JP2020059696A (en) | 2020-04-16 |
SI2692346T1 (en) | 2016-03-31 |
JP2018065828A (en) | 2018-04-26 |
JP2016106075A (en) | 2016-06-16 |
IL225010A (en) | 2016-04-21 |
TWI621611B (en) | 2018-04-21 |
HK1188717A1 (en) | 2014-05-16 |
GT201300093AA (en) | 2015-07-08 |
CY1117188T1 (en) | 2017-04-05 |
TW201412707A (en) | 2014-04-01 |
ZA201903284B (en) | 2021-01-27 |
KR101990936B1 (en) | 2019-06-19 |
KR20180026775A (en) | 2018-03-13 |
ZA201302269B (en) | 2021-05-26 |
ME02328B (en) | 2016-06-20 |
RS54619B1 (en) | 2016-08-31 |
JP6790202B2 (en) | 2020-11-25 |
HUE026832T2 (en) | 2016-07-28 |
IL261206B (en) | 2019-12-31 |
JP6586147B2 (en) | 2019-10-02 |
ZA201705519B (en) | 2019-04-24 |
ES2560842T3 (en) | 2016-02-23 |
HRP20151389T1 (en) | 2016-01-15 |
PT2692346E (en) | 2016-03-22 |
IL261206A (en) | 2018-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201390538A1 (en) | ANTI-VIRUS COMPOUNDS | |
EA201390190A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201390155A1 (en) | COMBINATION OF HEPATITIS C VIRUS INHIBITORS | |
EA201391152A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201270555A1 (en) | COMBINATION OF HEPATITIS C VIRUS INHIBITORS | |
MX346264B (en) | Anti-viral compounds. | |
EA201400115A1 (en) | ANTI-VIRUS COMPOUNDS | |
EA201370017A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201270622A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201691261A1 (en) | NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS | |
EA201270656A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201171208A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201101082A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201001275A1 (en) | CONFORMATION-LIMITED BIPHENYL DERIVATIVES FOR USE AS HEPATITIS C VIRUS INHIBITORS | |
MX336580B (en) | Methods for treating hcv. | |
EA201491179A1 (en) | 2 ', 4'-DIFFOROR-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS AN INHIBITORS REPLICATION RNA HEPATITIS C VIRUS | |
EA201491361A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201391637A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201370078A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201391685A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
EA201391717A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
MX354676B (en) | Benzofuran compounds for the treatment of hepatitis c virus infections. | |
EA201590770A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
UA113048C2 (en) | ANTI-VIRUS COMPOUNDS | |
UA108904C2 (en) | ANTI-VIRUS COMPOUNDS |